EP0725630A1 - Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs - Google Patents

Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs

Info

Publication number
EP0725630A1
EP0725630A1 EP94931939A EP94931939A EP0725630A1 EP 0725630 A1 EP0725630 A1 EP 0725630A1 EP 94931939 A EP94931939 A EP 94931939A EP 94931939 A EP94931939 A EP 94931939A EP 0725630 A1 EP0725630 A1 EP 0725630A1
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
composition according
aluminum silicate
magnesium aluminum
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94931939A
Other languages
German (de)
English (en)
Inventor
Michelle Elizabeth Brideau
Anne Marie Carella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP0725630A1 publication Critical patent/EP0725630A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composition d'adsorbat comprenant du silicate de magnésium et d'aluminium et au moins deux substances actives pharmaceutiquement acceptables, présentée sous une forme posologique se dissolvant rapidement.
EP94931939A 1993-10-28 1994-10-20 Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs Withdrawn EP0725630A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14459293A 1993-10-28 1993-10-28
PCT/US1994/012018 WO1995011671A1 (fr) 1993-10-28 1994-10-20 Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs
US144592 2002-05-09

Publications (1)

Publication Number Publication Date
EP0725630A1 true EP0725630A1 (fr) 1996-08-14

Family

ID=22509264

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94931939A Withdrawn EP0725630A1 (fr) 1993-10-28 1994-10-20 Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs

Country Status (4)

Country Link
EP (1) EP0725630A1 (fr)
JP (1) JPH09504293A (fr)
AU (1) AU8084594A (fr)
WO (1) WO1995011671A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3693397A (en) * 1996-07-10 1998-02-02 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
MY119059A (en) † 1997-08-11 2005-03-31 Cadbury Adams Usa Llc Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same
US7588793B1 (en) 1998-06-05 2009-09-15 Cadbury Adams Usa, Llc Enhanced flavoring compositions containing N-ethyl-p-menthane-3-carboxamide and method of making and using same
SK288117B6 (sk) * 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AU2005272802B2 (en) 2004-08-11 2009-07-02 Intercontinental Great Brands Llc Sensate compositions and delivery systems therefor
PL1836665T3 (pl) 2004-11-19 2013-06-28 Glaxosmithkline Llc Sposób dostosowywania dozowania zmiennych dawek leków w produktach skojarzonych w celu indywidualizowania terapii
PL1973422T3 (pl) 2005-12-23 2014-09-30 Intercontinental Great Brands Llc Kompozycje zapewniające wrażenie ogrzewania do dostarczania doustnego i skórnego
EP2413883A1 (fr) 2009-04-01 2012-02-08 Colgate-Palmolive Company Compositions de dentifrice et procédés de traitement et de prévention de dommages à des surfaces de dent
CN103635096B (zh) 2011-04-29 2016-08-17 洲际大品牌有限责任公司 被包封的酸、其制备方法及包括所述被包封的酸的咀嚼型胶基糖

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
BR9205827A (pt) * 1991-04-04 1994-06-28 Procter & Gamble Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior
WO1994020074A1 (fr) * 1993-03-12 1994-09-15 The Procter & Gamble Company Compositions a base d'adsorbats

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9511671A1 *

Also Published As

Publication number Publication date
AU8084594A (en) 1995-05-22
JPH09504293A (ja) 1997-04-28
WO1995011671A1 (fr) 1995-05-04

Similar Documents

Publication Publication Date Title
US5560913A (en) Pharmaceutical compositions
US5196436A (en) Dextromethorphan antitussive compositions
US6027746A (en) Chewable soft gelatin-encapsulated pharmaceutical adsorbates
AU681672B2 (en) Preparations containing silicon dioxide to improve the taste thereof
US5458879A (en) Oral vehicle compositions
US4716033A (en) Medicament adsorbates with surfactant and their preparation
JP5177447B2 (ja) 速溶性及び可撓性を有するフィルム製剤
EP1370247B1 (fr) Compositions pharmaceutiques au gout dissimule
US5958445A (en) Oral Formulations of S(+)-etodolac
PT1082106E (pt) Comprimido efervescente para administração subligual, bucal e gengival de fentanil
US5730997A (en) Tastemasked liquid pharmaceutical delivery system
WO1995011671A1 (fr) Formes posologiques a dissolution rapide contenant du silicate de magnesium et d'aluminium et plusieurs ingredients actifs
EP0762869A1 (fr) Formes galeniques a dissolution rapide
CA1333773C (fr) Compositions antitussives liquides contenant du phenol
US20030039687A1 (en) Taste masking composition
WO1994020074A1 (fr) Compositions a base d'adsorbats
WO1999038496A1 (fr) Produits pharmaceutiques a dissolution rapide
US20060198856A1 (en) Ibuprofen suspension stabilized with docusate sodium
CA2129676C (fr) Compositions antitussive de dextromethorphane
JPH0656677A (ja) 制酸剤組成物
CA2175225C (fr) Substance a pouvoir moussant garnissant une gelule de gelatine
WO2002009666A1 (fr) Compositions pharmaceutiques impromptues
MXPA96006041A (en) Dosage form of rapida disoluc

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960410

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19990315

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990928